Disability Level of Leprosy Patients in Ambon City, Maluku: A Retrospective Study from Eastern Indonesia
Downloads
Background: Leprosy, also known as Hansen's disease, is a chronic endemic disease. The Corona Virus Disease 2019 (COVID-19) pandemic disrupted the implementation of the Neglected Tropical Diseases (NTDs) program such as the leprosy new case detection program. Leprosy is one of the chronic diseases that causes various problems due to the disability it causes. Purpose: To know the prevalence of leprosy and disability in 2018-2022 in Ambon City, Maluku, Indonesia. Methods: This research is a type of retrospective descriptive research whose aim is to find out the epidemiology of leprosy patients in Ambon City, Maluku, Indonesia with a sample of were 131 people from 2018 to 2022. Result: The prevalence of disability levels 0 and 2 has the highest percentage in the 5-year span, occurring in 2019. However, during the COVID -19 pandemic, cases of level 1 disability tend to rise. Conclusion: Leprosy patients who had disability were more common than those who had a disability.
Kementrian Kesehatan Republik Indonesia. Pedoman nasional pelayanan kedokteran tatalaksana kusta. 2019; p.1–64.
Barroso DH, Brandí£o JG, Andrade ESN, Correia ACB, Aquino DC, Chen ACR, et al. Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis. BMC Infect Dis 2021; 21(1):p.1–9.
Brakel WH van, Sihombing B, Djarir H, Beise K, Kusumawardhani L, Yulihane R, et al. Disability in people affected by leprosy: The role of impairment, activity, social participation, stigma and discrimination. Coaction Publ 2012; 1(5): p.1–11.
WHO. Weekly epidemiological record Relevé épidémiologique hebdomadaire. Epidemiol J 2021; 2021(36): p.421–44.
Figueiredo V De, Gandini M, Cristina M, Pessolani V. Modulation of the response to mycobacterium leprae and pathogenesis of leprosy. Fontiers Microbiol Microbiol 2022; 13(1): p.1–12.
Sarode G, Sarode S, Anand R, Patil S, Jafer M, Baeshen H, et al. Epidemiological aspects of leprosy. Disease-a-Month 2020; 66(7): p.1–8.
Pusat Data dan Informasi Kementrian Kesehatan Republik Indonesia. Hapuskan stigma dan diskriminasi terhadap kusta. 2018. p.7.
Dinas Kesehatan Kota Ambon. Data profil dinas kesehatan kota ambon. Ambon: 2022. p.1.
Maymone MBC, Venkatesh S, Laughter M, Abdat R, Hugh J, Dacso MM, et al. Leprosy: Treatment and management of complications. J Am Acad Dermatol [Internet] 2020; 83(1): p.17–30.
Kementrian Kesehatan Indonesia. Pengendalian Penyakit Kusta. 6th ed. Jakarta: 2019. p.167.
Supriyanto Suparno A, Tosepu R, Effendy DS. Leprosy Cases in South Konawe Regency Based on Surveillance Data of the South Konawe Regency Health Office, Southeast Sulawesi Province, Indonesia. KnE Life Sci 2022; 2022(1): p.72–7.
Santos VS, de Matos AMS, de Oliveira LSA, de Lemos LMD, Gurgel RQ, Reis FP, et al. Clinical variables associated with disability in leprosy cases in northeast Brazil. J Infect Dev Ctries 2015; 9(3): p.232–8.
Tiya Nur Widya, Mateus Sakundarno Adi M. Gambaran faktor risiko kecacatan pada penderita kusta. J Kesehat Masy 2019; 7(2): p.54–9.
Geani S, Rahmadewi R, Astindari A, Prakoeswa CRS, Sawitri S, Ervianti E, et al. Profile of disability in leprosy patients: a retrospective study. Berk Ilmu Kesehat Kulit dan Kelamin 2022; 34(2): p.109–13.
Geani S, Rahmadewi, Astindari, Prakoeswa CRS, Sawitri, Ervianti E, et al. Risk factors for disability in leprosy patients: a cross-sectional study. Bali Med J 2022; 11(1): p.197–201.
da Paz WS, Souza M do R, Tavares D dos S, de Jesus AR, dos Santos AD, do Carmo RF, et al. Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study. Lancet Reg Heal - Am 2022; 9(1): p.1–10.
Copyright (c) 2023 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
